Stock listing
Frankfurt:NB3 Neurocrine Biosciences, Inc. Aktie
German listing (Frankfurt) of Neurocrine Biosciences, Inc. · home listing NASDAQ:NBIX
Follow Neurocrine Biosciences, Inc. into a list and get an email when it puts out news.
Share price · FWB:NB3
€129.60 EUR +3.35 (+2.7%)
Close on Oct 30, 2026
- Day range
- €129.60 – €129.60 EUROct 30, 2026
- Market cap
- €13.17B EURAt the close on Oct 30, 2026 · price × 101.6M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NBIX · Home | $164.85 USD | +19.50 (+13.4%) | 4,056,105 | $159.00 | $169.53 | $157.91 | $145.35 | Close on Nov 3, 2026 |
| Frankfurt:NB3 | €129.60 EUR | +3.35 (+2.7%) | — | €129.60 | €129.60 | €129.60 | €126.25 | Close on Oct 30, 2026 |
| LSE:0K6R | $145.30 USD | +3.45 (+2.4%) | 623 | $143.50 | $146.91 | $143.50 | $141.85 | Close on Oct 27, 2026 |
| B3:N1BI34 | 39.20 BRL | +3.48 (+9.7%) | 2,147 | 39.12 | 39.24 | 38.72 | 35.72 | Close on Oct 27, 2026 |
| Munich:NB3 | €129.35 EUR | +2.80 (+2.2%) | — | €129.35 | €129.35 | €129.35 | €126.55 | Close on Oct 27, 2026 |
- Ticker
- Frankfurt:NB3
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 3, 2026
Neurocrine Biosciences to Spotlight Its Scientific Journey and Growing Neuropsychiatry Pipeline at 2026 NEI Fall Congress
Latest earnings call · Nov 2, 2026
Neurocrine Biosciences (NASDAQ:NBIX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 2, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Calls
Replays
Neurocrine Biosciences (NASDAQ:NBIX) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Watch TranscriptNeurocrine Biosciences (NASDAQ:NBIX) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 4:30 PM ET
Watch TranscriptNeurocrine Biosciences (NASDAQ:NBIX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Decks
Q3 2026 Earnings Presentation
Earnings · 15 slides · Nov 2, 2026
Q1 2026 Earnings Presentation
Earnings · 15 slides · May 5, 2026
Merger or Acquisition (April 2026)
Merger or acquisition · 12 slides · Apr 6, 2026
Q4 2025 Earnings Presentation
Earnings · 71 slides · Feb 11, 2026
Neurocrine Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 55 in the last 12 months · 278 in all · newest Nov 3, 2026 · oldest 2019
- Calls
- 17 calls with a replay · 17 with a transcript · latest Nov 2, 2026
- Decks
- 16 decks · latest Nov 2, 2026
Where Neurocrine Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NBIX · Home listing | NASDAQ | United States | USD |
| gettex:NB3 | gettex | Germany | EUR |
| Lang & Schwarz:900964 | Lang & Schwarz | Germany | EUR |
| Frankfurt:NB3 · This page | Frankfurt | Germany | EUR |
| LS Exchange:900964 | LS Exchange | Germany | EUR |
| BMV:NBIX | BMV | Mexico | MXN |
| LSE:0K6R | LSE | United Kingdom | USD |
| B3:N1BI34 | B3 | Brazil | BRL |
| Tradegate:NB3 | Tradegate | Germany | EUR |
| Milan:1NBIX | Milan | Italy | EUR |
| BIVA:NBIX | BIVA | Mexico | MXN |
| BOATS:NBIX | BOATS | United States | USD |
| BX Swiss:NB3 | BX Swiss | Switzerland | CHF |
| Dusseldorf:NB3 | Dusseldorf | Germany | EUR |
| Munich:NB3 | Munich | Germany | EUR |
| Stuttgart:NB3 | Stuttgart | Germany | EUR |
| Hamburg:NB3 | Hamburg | Germany | EUR |
| Hanover:NB3 | Hanover | Germany | EUR |
| Xetra:NB3 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Neurocrine Biosciences, Inc.